Best Exosome / Extracellular Vesicle CDMOs by Signal Score

← All Exosome CDMOs Best Clean FDA History Commercial Scale
6
CDMOs tracked
6
Fully scored
1
With FDA records
1
FDA inspections

Exosome and extracellular vesicle (EV) CDMOs manufacture next-generation delivery vehicles for RNA, proteins, and small molecules. As an emerging modality, the field is still standardizing cell-source, isolation, and potency methods.

Choosing an exosome CDMO turns on cell-source and culture scale, isolation method (TFF, chromatography), characterization, and a clean regulatory record. The rankings below score each CDMO on FDA inspections, GMP certification, clinical activity, and capacity.

FDA inspection outcomes across these CDMOs: 1 NAI (no action), 0 VAI (voluntary action), 0 OAI (official action). Leading inspection & GMP sites: United States (1).

Last updated 2026-03-21. Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

# CDMO Signal Score Quality FDA · GMP Capacity Programs
1
CK
Codiak BioSciences (Sarepta)
Cambridge, MA
 78.0 100.0 1 insp · 0 GMP — 16 programs
2
EA
Esco Aster
Singapore, SG
 63.0 — — — 0 programs
3
EV
Evox Therapeutics
Oxford, UK
 57.5 — — — 0 programs
4
EXO
ExoXpert (EXO Biologics)
Liege, BE
 56.5 — — — 0 programs
5
EP
Exopharm
Melbourne, AU
 56.5 — — — 0 programs
6
CLB
Clara Biotech
Indianapolis, IN
 56.5 — — — 0 programs
How we score CDMOs →

What to evaluate in a Exosome / Extracellular Vesicle CDMO

Cell source & scale
Confirm the producer cell source and whether culture is suspension-adapted for the volumes EV yields demand.
Isolation & purification
Isolation method (tangential-flow filtration, chromatography) drives yield, purity, and scalability. Ask how it performs at your target scale.
Characterization & potency
EV characterization (particle count, size, cargo, identity) and potency assays are still maturing — look for established, qualified methods.
Regulatory track record
Cross-check FDA 483 history and EMA/MHRA GMP coverage — both shown above and on each profile.

Exosome / Extracellular Vesicle CDMOs — Frequently Asked Questions

Who are the top Exosome / Extracellular Vesicle CDMOs?
By CDMO Signal's independent Signal Score, the top-ranked Exosome / Extracellular Vesicle CDMOs include Codiak BioSciences (Sarepta), Esco Aster, Evox Therapeutics. See the full ranked table above — scored on FDA, clinical, financial, and capacity data.
How many Exosome / Extracellular Vesicle CDMOs have FDA inspection records?
CDMO Signal tracks 1 Exosome / Extracellular Vesicle CDMO with FDA inspection records and 0 EMA/MHRA GMP certificates across the group.
What should I look for in an exosome CDMO?
Confirm cell source and scalable culture, a robust isolation method (TFF or chromatography), qualified characterization and potency analytics, and a clean FDA and EMA/MHRA record.
Is exosome manufacturing standardized?
Not yet fully — cell-source, isolation, and potency methods are still maturing across the field, so a CDMO's specific platform and analytics maturity matter more than in established modalities.
Related modalities
mRNA / LNP CDMOs Cell Therapy CDMOs Biologics / mAb CDMOs
Other Modalities
AAV CAR-T Lentiviral Cell Therapy mRNA/LNP Plasmid DNA Biologics Oligo/ASO Adenoviral Gene Editing Recombinant Proteins ADC